Longitudinal changes of insight in first episode psychosis and its relation to clinical symptoms, treatment adherence and global functioning: One-year follow-up from the Eiffel study - 28/12/11
, N. Ojeda b, e, J. Peña b, J. García a, A. Rodriguez-Morales f, I. Ruiz f, R. Hidalgo f, J.A. Burón f, J.I.I. Eguiluz a, c, e, M. Gutiérrez c, d, e
Corresponding author. Tel.: +34 94 600 6004; fax: +34 94 600 6294.Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 7 |
| Iconographies | 1 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
Objectives |
The Eiffel study is a longitudinal, naturalistic study of patients with first episode psychosis (FEP) designed to evaluate the predictive value of defective insight on treatment adherence and global functioning.
Methods |
Five hundred seventy-seven patients with FEP were assessed at baseline and at a 1-year follow-up. They were compared in terms of sociodemographic factors, psychopathology, insight, treatment adherence and functional outcome. Longitudinal functionality was prospectively assessed with the clinical global impression (CGI) and global assessment of functioning (GAF) rating scales.
Results |
At baseline, up to 50% of our sample presented with a lack of insight. Most clinical symptoms, including insight, improved over the follow-up period. Insight, education and social withdrawal significantly predicted CGI and GAF at follow-up. Insight and level of education were predictive of treatment adherence.
Conclusions |
Insight significantly predicted the general clinical course, treatment adherence and functional outcome in our FEP sample after 1 year. Only education additionally accounted for the longitudinal course. Since our results suggest that better insight improves treatment adherence and consequently clinical course and functional outcome, insight could be a specific target of treatment in early intervention programs.
Le texte complet de cet article est disponible en PDF.Keywords : First-episode psychosis, Insight, Treatment adherence, Longitudinal course, Functional outcome, Risperidone
Plan
Vol 27 - N° 1
P. 43-49 - janvier 2012 Retour au numéro
Article précédent
- Type-2 diabetes mellitus in schizophrenia: Increased prevalence and major risk factor of excess mortality in a naturalistic 7-year follow-up
- D. Schoepf, R. Potluri, H. Uppal, A. Natalwala, P. Narendran, R. Heun
- A four-year naturalistic prospective study of cardiometabolic disease in antipsychotic-treated patients
- P. Mackin, T. Waton, H.M. Watkinson, P. Gallagher
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?